Holen Sie sich die Stockscreener-App
12.08
3.25%
0.38
Schlusskurs vom Vortag:
$11.70
Offen:
$11.7
24-Stunden-Volumen:
14,474
Relative Volume:
0.70
Marktkapitalisierung:
$7.92M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-19.47M
KGV:
-0.4733
EPS:
-25.5243
Netto-Cashflow:
$-15.57M
1W Leistung:
+9.32%
1M Leistung:
+4.50%
6M Leistung:
-55.27%
1J Leistung:
-85.91%
1-Tages-Spanne:
$11.20
$12.08
1-Wochen-Bereich:
$10.73
$12.08
52-Wochen-Spanne:
$8.67
$196.70
Envveno Medical Corp Stock (NVNO) Company Profile
Firmenname
Envveno Medical Corp
Sektor
Branche
Telefon
949-261-2900
Adresse
70 DOPPLER, IRVINE
Compare NVNO vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVNO
Envveno Medical Corp
|
12.08 | 7.67M | 0 | -19.47M | -15.57M | -25.52 |
ABT
Abbott Laboratories
|
96.00 | 166.82B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 129.58B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 109.13B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 90.64B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.95B | 6.07B | 1.06B | 1.34B | 1.8063 |
Envveno Medical Corp Aktie (NVNO) Neueste Nachrichten
MSN Money - MSN
What is enVVeno Medical Corporations market position2026 Price Swings & AI Driven Stock Movement Reports - baoquankhu1.vn
enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System - The Florida Times-Union
Stop Loss: What is enVVeno Medical Corporations market positionQuarterly Market Review & Technical Entry and Exit Alerts - baoquankhu1.vn
Whats the profit margin of enVVeno Medical Corporation2026 Market Mood & Risk Managed Investment Signals - baoquankhu1.vn
NVNO PE Ratio & Valuation, Is NVNO Overvalued - Intellectia AI
enVVeno Medical Shares Crash After FDA Reaffirms VenoValve Rejection - MSN
Dow Update: Is enVVeno Medical Corporation a strong candidate for buy and holdMarket Trend Report & Consistent Profit Alerts - baoquankhu1.vn
Market Wrap: Whats the MACD signal for enVVeno Medical Corporation2026 Short Interest & Daily Profit Maximizing Tips - baoquankhu1.vn
enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - The News-Star
enVVeno Medical Corp (NVNO) SEC filings - GuruFocus
enVVeno Medical Corp (NVNO) Stock Earnings Transcripts - GuruFocus
enVVeno Medical Reports FY GAAP EPS of -$33.06 Amid Reverse Stock Split - Intellectia AI
Market Pulse: Whats the MACD signal for enVVeno Medical Corporation2026 Technical Patterns & Weekly Top Gainers Alerts - baoquankhu1.vn
AI Models Reiterate High-Risk, Speculative View on enVVeno Medical (NVNO) - TipRanks
enVVeno Medical reports FY25 EPS ($33.06) vs. ($44.53) last year - TipRanks
EnVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of EnVVe(R) System - 富途牛牛
enVVeno Medical (NVNO) full year 2025 financial results - grafa.com
[10-K] enVVeno Medical Corp Files Annual Report - Stock Titan
enVVeno Medical 10-K: Net loss $19.5M, no revenue, EPS not disclosed - TradingView
5HJ0 Stock Price and Chart — FWB:5HJ0 - TradingView
If You Invested $1,000 in Envveno Medical Corporation (NVNO) - Stock Titan
NVNO's Shares Decline on Unfavorable FDA Review Outcome for VenoValve - MSN
Insider Sell: Francis Duhay Sells Shares of enVVeno Medical Corp (NVNO) - GuruFocus
[144] enVVeno Medical Corp SEC Filing - Stock Titan
Volatility Watch: Is enVVeno Medical Corporation a strong candidate for buy and hold2026 Spike Watch & Safe Capital Preservation Plans - baoquankhu1.vn
enVVeno Medical (NVNO) Stock Analysis Report | Financials & Insights - Benzinga Japan
NorthStrive Fund II LP Calls on enVVeno Medical to Halt Clinical Spending Plans and Call Special Shareholder Meeting to Vote on Strategic Alternatives - The Manila Times
Reviewing Pressure BioSciences (OTCMKTS:PBIO) & enVVeno Medical (NASDAQ:NVNO) - Defense World
NVNO SEC FilingsEnvveno Medical Corporation 10-K, 10-Q, 8-K Forms - Stock Titan
NVNO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Can enVVeno Medical Corporation maintain sales growthQuarterly Profit Summary & Daily Growth Stock Tips - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
enVVeno Medical (NVNO) investor urges halt to trials, strategic review - Stock Titan
enVVeno Medical Announces Reverse Stock Split - Press & Sun-Bulletin
Perceptive funds hold 2.05M enVVeno (NVNO) shares and warrants - Stock Titan
Finanzdaten der Envveno Medical Corp-Aktie (NVNO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):